• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长分化因子15水平与儿童代谢功能障碍相关脂肪性肝病的关系

Levels of Growth Differentiation Factor 15 Correlated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Children.

作者信息

Mosca Antonella, Braghini Maria Rita, Andolina Giulia, De Stefanis Cristiano, Cesarini Lucia, Pastore Anna, Comparcola Donatella, Monti Lidia, Francalanci Paola, Balsano Clara, Pietrobattista Andrea, Alisi Anna, Panera Nadia

机构信息

Hepatology and Liver Transplant Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Research Unit of Genetics of Complex Phenotypes, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

出版信息

Int J Mol Sci. 2025 Jul 5;26(13):6486. doi: 10.3390/ijms26136486.

DOI:10.3390/ijms26136486
PMID:40650260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12249647/
Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic progressive hepatopathy in children, and the identification of non-invasive biomarkers is urgently needed. Growth differentiation factor 15 (GDF15) was associated with MASLD in adults. In this study, we investigated the circulating and hepatic levels of GDF15 and their association with liver damage in pediatric MASLD and in a murine model. This observational study included 158 children with biopsy-proven MASLD. Patients with MASLD were categorized into two groups based on steatohepatitis (MASH) presence and evaluated for GDF15 circulating levels, while GDF15 hepatic levels were assessed only in a subset of patients. Children with MASLD exhibited higher levels of circulating GDF15 compared to the controls. Moreover, the MASH subgroup had significantly higher values of GDF15 compared to the Not-MASH subgroup. The GDF15 levels in the MASH subgroup showed a positive correlation with fibrosis. Finally, the hepatic expression of the GDF15 gene correlated with GDF15 circulating levels and with the hepatic expression of the COL1A1 and COL3A1 genes in 15 children with MASLD. In conclusion, our study demonstrated that GDF15 levels are associated with liver damage, reinforcing the potential role of GDF15 as a biomarker for MASLD-related fibrosis in children.

摘要

代谢功能障碍相关脂肪性肝病(MASLD)是儿童中最常见的慢性进行性肝病,因此迫切需要鉴定非侵入性生物标志物。生长分化因子15(GDF15)与成人MASLD相关。在本研究中,我们调查了儿童MASLD及小鼠模型中GDF15的循环水平和肝脏水平及其与肝损伤的关系。这项观察性研究纳入了158例经活检证实为MASLD的儿童。根据是否存在脂肪性肝炎(MASH)将MASLD患者分为两组,并评估其GDF15循环水平,而仅在部分患者中评估GDF15肝脏水平。与对照组相比,MASLD儿童的循环GDF15水平更高。此外,与非MASH亚组相比,MASH亚组的GDF15值显著更高。MASH亚组中的GDF15水平与纤维化呈正相关。最后,在15例MASLD儿童中,GDF15基因的肝脏表达与GDF15循环水平以及COL1A1和COL3A1基因的肝脏表达相关。总之,我们的研究表明GDF15水平与肝损伤相关,强化了GDF15作为儿童MASLD相关纤维化生物标志物的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/4ec555e812d1/ijms-26-06486-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/a472478184ab/ijms-26-06486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/cf79ca4a47e6/ijms-26-06486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/70bb68a86824/ijms-26-06486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/eaba7c34ce38/ijms-26-06486-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/4ec555e812d1/ijms-26-06486-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/a472478184ab/ijms-26-06486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/cf79ca4a47e6/ijms-26-06486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/70bb68a86824/ijms-26-06486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/eaba7c34ce38/ijms-26-06486-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/12249647/4ec555e812d1/ijms-26-06486-g005.jpg

相似文献

1
Levels of Growth Differentiation Factor 15 Correlated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Children.生长分化因子15水平与儿童代谢功能障碍相关脂肪性肝病的关系
Int J Mol Sci. 2025 Jul 5;26(13):6486. doi: 10.3390/ijms26136486.
2
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.水飞蓟素用于患有代谢功能障碍相关脂肪性肝病的成年人。
Cochrane Database Syst Rev. 2025 Jun 24;6(6):CD015524. doi: 10.1002/14651858.CD015524.pub2.
3
The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study.吉尔伯特综合征在代谢功能障碍相关脂肪性肝病(MASLD)患者中的意义:一项回顾性队列研究
Cureus. 2025 May 30;17(5):e85074. doi: 10.7759/cureus.85074. eCollection 2025 May.
4
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.代谢功能障碍相关脂肪性肝病:肌肉与体重的故事。
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
5
A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease.饮食驱动的代谢功能障碍相关脂肪性肝炎(MASH)小鼠模型类似于相应的人类疾病。
J Mol Histol. 2025 May 20;56(3):162. doi: 10.1007/s10735-025-10449-9.
6
Linking gut permeability to liver steatosis: Noninvasive biomarker evaluation in MASLD patients - a prospective cross-sectional study.将肠道通透性与肝脂肪变性联系起来:非酒精性脂肪性肝病患者的非侵入性生物标志物评估——一项前瞻性横断面研究。
Medicine (Baltimore). 2025 May 23;104(21):e42476. doi: 10.1097/MD.0000000000042476.
7
Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in metabolic dysfunction-associated steatotic liver disease.多参数超声用于代谢功能障碍相关脂肪性肝病中肝脂肪变性、纤维化和炎症的无创评估
World J Gastroenterol. 2025 Jul 7;31(25):105518. doi: 10.3748/wjg.v31.i25.105518.
8
Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence.使用可解释人工智能将细胞外囊泡作为代谢功能障碍相关脂肪性肝病分期的生物标志物
World J Gastroenterol. 2025 Jun 14;31(22):106937. doi: 10.3748/wjg.v31.i22.106937.
9
Evaluation of the prevalence of MASLD, MASH and liver fibrosis in a Dutch bariatric cohort.荷兰肥胖症队列中代谢功能障碍相关脂肪性肝病(MASLD)、非酒精性脂肪性肝炎(MASH)和肝纤维化患病率的评估。
PLoS One. 2025 Jun 24;20(6):e0324813. doi: 10.1371/journal.pone.0324813. eCollection 2025.
10
Multi-Cohort Exploration of Repetitive Element Transcription and DNA Methylation in Human Steatotic Liver Disease.人类脂肪性肝病中重复元件转录和DNA甲基化的多队列探索
Int J Mol Sci. 2025 Jun 8;26(12):5494. doi: 10.3390/ijms26125494.

本文引用的文献

1
Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病患者循环及肝脏中生长分化因子15的水平
Hepatol Res. 2025 Apr;55(4):492-504. doi: 10.1111/hepr.14148. Epub 2024 Dec 4.
2
Key Insights into Gut Alterations in Metabolic Syndrome.代谢综合征中肠道改变的关键见解
J Clin Med. 2025 Apr 14;14(8):2678. doi: 10.3390/jcm14082678.
3
GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease.
生长分化因子15循环水平与代谢相关肝损伤及动脉粥样硬化性心血管疾病相关。
Int J Mol Sci. 2025 Feb 26;26(5):2039. doi: 10.3390/ijms26052039.
4
GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies.生长分化因子15(GDF-15)提高了脂肪性肝病非侵入性检测对心肾代谢疾病和恶性肿瘤发病及死亡风险的预测能力。
Metabolism. 2025 Feb;163:156047. doi: 10.1016/j.metabol.2024.156047. Epub 2024 Oct 12.
5
Growth differentiation factor 15: Emerging role in liver diseases.生长分化因子 15:在肝脏疾病中的新作用。
Cytokine. 2024 Oct;182:156727. doi: 10.1016/j.cyto.2024.156727. Epub 2024 Aug 6.
6
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study.经活检证实的脂肪性肝病和脂肪性肝炎患者的循环激素:一项多中心观察性研究。
Metabolism. 2023 Nov;148:155694. doi: 10.1016/j.metabol.2023.155694. Epub 2023 Sep 25.
7
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新脂肪性肝病命名。
Ann Hepatol. 2024 Jan-Feb;29(1):101133. doi: 10.1016/j.aohep.2023.101133. Epub 2023 Jun 24.
8
Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver disease.儿童脂肪肝的诊断应与对其他肝病病因的调查同时进行。
Lancet Gastroenterol Hepatol. 2023 Jul;8(7):598-600. doi: 10.1016/S2468-1253(23)00100-0. Epub 2023 Apr 4.
9
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019.全球和国家青少年非酒精性脂肪性肝病的患病率:2019 年全球疾病负担研究分析。
Hepatology. 2023 Oct 1;78(4):1168-1181. doi: 10.1097/HEP.0000000000000383. Epub 2023 Apr 10.
10
Overview of growth differentiation factor 15 in metabolic syndrome.代谢综合征中生长分化因子 15 概述。
J Cell Mol Med. 2023 May;27(9):1157-1167. doi: 10.1111/jcmm.17725. Epub 2023 Mar 29.